Literature DB >> 513267

Electron microscopic studies on the alveolar-capillary barrier in the patients of chronic pulmonary edema.

Y S Lee.   

Abstract

Electron microscopic studies on the alveolar-capillary barrier were carried out in 13 patients of chronic pulmonary edema and/or congestion resulting from heart disease of various etiologies. The characteristic findings are tremendous proliferation of type II granular pneumocyte and irregular thickening of alveolar epithelial and capillary basement membrane. These ultrastructural changes correlated to the duration of heart failure and mean pulmonary arterial wedge pressure despite of disease groups and the age of the patients. In particular, lamination of capillary basement membrane with fragmentation was more specific finding which was observed only in patients with mean pulmonary arterial wedge pressure above 35 mmHg and duration of heart failure over 6 hears. There was no apparent relationship existed between the ultrastructural changes and pulmonary arterial pressure. In addition to these characteristic changes the remaining ultrastructural changes of the alveolar-capillary barrier were difficult to make a correlation to clinical course and cardio-pulmonary hemodynamics.

Entities:  

Mesh:

Year:  1979        PMID: 513267     DOI: 10.1253/jcj.43.945

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  10 in total

Review 1.  Pulmonary hypertension with left-sided heart disease.

Authors:  Marco Guazzi; Ross Arena
Journal:  Nat Rev Cardiol       Date:  2010-10-05       Impact factor: 32.419

Review 2.  Diffuse Alveolar Hemorrhage in Cardiac Diseases.

Authors:  Biplab K Saha; Woon H Chong
Journal:  Lung       Date:  2021-03-11       Impact factor: 2.584

3.  Downregulation of aquaporin-1 in alveolar microvessels in lungs adapted to chronic heart failure.

Authors:  Katrine M Müllertz; Claes Strøm; Simon Trautner; Ole Amtorp; Søren Nielsen; Sten Christensen; Stig Haunsø; Thomas E N Jonassen
Journal:  Lung       Date:  2011-01-04       Impact factor: 2.584

Review 4.  WHO's in second?: A practical review of World Health Organization group 2 pulmonary hypertension.

Authors:  Sif Hansdottir; Dayna J Groskreutz; Brian K Gehlbach
Journal:  Chest       Date:  2013-08       Impact factor: 9.410

5.  Impaired Pulmonary Diffusion in Heart Failure With Preserved Ejection Fraction.

Authors:  Thomas P Olson; Bruce D Johnson; Barry A Borlaug
Journal:  JACC Heart Fail       Date:  2016-06       Impact factor: 12.035

Review 6.  Lung morphology and surfactant function in cardiogenic pulmonary edema: a narrative review.

Authors:  Kenneth Nugent; Logan Dobbe; Rubayat Rahman; Mohamed Elmassry; Pablo Paz
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

7.  Wedge Pressure Rather Than Left Ventricular End-Diastolic Pressure Predicts Outcome in Heart Failure With Preserved Ejection Fraction.

Authors:  Julia Mascherbauer; Caroline Zotter-Tufaro; Franz Duca; Christina Binder; Matthias Koschutnik; Andreas A Kammerlander; Stefan Aschauer; Diana Bonderman
Journal:  JACC Heart Fail       Date:  2017-10-11       Impact factor: 12.035

8.  Association of lung diffusion capacity with cardiac remodeling and risk of heart failure: The Framingham heart study.

Authors:  Ibrahim Musa Yola; Albin Oh; Gary F Mitchell; George O'Connor; Susan Cheng; Ramachandran S Vasan; Vanessa Xanthakis
Journal:  PLoS One       Date:  2021-02-16       Impact factor: 3.240

9.  Ventilation heterogeneity is increased in patients with chronic heart failure.

Authors:  Kirk Kee; Christopher Stuart-Andrews; Kris Nilsen; Jeremy P Wrobel; Bruce R Thompson; Matthew T Naughton
Journal:  Physiol Rep       Date:  2015-10

Review 10.  Pulmonary hypertension in chronic heart failure: definitions, advances, and unanswered issues.

Authors:  Emmanuelle Berthelot; Fabrice Bauer; Jean-Christophe Eicher; Erwan Flécher; Barnabas Gellen; Julien Guihaire; Damien Guijarro; Gérald Roul; Muriel Salvat; Christophe Tribouilloy; Florian Zores; Nicolas Lamblin; Pascal de Groote; Thibaud Damy
Journal:  ESC Heart Fail       Date:  2018-07-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.